News
AstraZeneca chief executive Sir Pascal Soriot is reportedly considering the move due to growing frustration with the UK's ...
Oruka Therapeutics, Inc. ('Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback